U.S. Erythropoietin (EPO) Drugs Market Strengthens as Amgen Leads Innovation, with Global Market Rising from USD 13.8 billion in 2026 to USD 22.7 billion by 2036 at a 5.1% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The global erythropoietin (EPO) drugs market is projected to grow from USD 13.8 billion in 2026 to USD 22.7 billion by 2036, registering a compound annual...